Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for prevention of renal scarring in pediatric acute pyelonephritis
IRCT20231226060526N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in acute pyelonephritis and kidney fibrosis, sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Renal scarring on follow-up imaging. Started Feb 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
acute pyelonephritiskidney fibrosis
Beyond the preview
Go deeper on IRCT20231226060526N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231226060526N1.